hypotaurine has been researched along with Bisphosphonate Osteonecrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enomoto, A; Kaneko, M; Miyano, K; Ota, S; Soga, T; Sugimoto, M; Ueno, T; Uezono, Y; Ushijima, T; Yatsuoka, W | 1 |
1 other study(ies) available for hypotaurine and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw.
Topics: Aged; Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Case-Control Studies; Electrophoresis, Capillary; Female; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Saliva; Taurine | 2019 |